Holen Sie sich die Stockscreener-App
2.17
3.56%
-0.08
Handel nachbörslich:
2.21
0.04
+1.84%
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Expenses
|
0.31%
15.42
|
15.47 | 17.10 | 18.84 | 19.10 |
| Nonoperating Income/Loss |
13.44%
1.643
|
1.898 | 2.064 | 2.231 | 2.654 |
| Income/Loss From Continuing Operations Before Tax |
1.52%
-13.78
|
-13.57 | -15.03 | -16.61 | -16.45 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
1.52%
-13.78
|
-13.57 | -15.03 | -16.61 | -16.45 |
|
Net Income/Loss
|
1.52%
-13.78
|
-13.57 | -15.03 | -16.61 | -16.45 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.97%
0.038
|
126.31 | 126.20 | 126.14 | 125.45 |
| Diluted Average Shares |
99.97%
0.038
|
126.31 | 126.20 | 126.14 | 125.45 |
| Basic Earnings Per Share |
0.00%
-0.11
|
-0.11 | -0.12 | -0.13 | -0.13 |
| Diluted Earnings Per Share |
0.00%
-0.11
|
-0.11 | -0.12 | -0.13 | -0.13 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.27%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):